<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Medifast Inc — News on 6ix</title>
<link>https://6ix.com/company/medifast-inc</link>
<description>Latest news and press releases for Medifast Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/medifast-inc" rel="self" type="application/rss+xml" />
<item>
<title>Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-to-announce-financial-results-for-the-first-quarter-ended-march-31-2026</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-to-announce-financial-results-for-the-first-quarter-ended-march-31-2026</guid>
<pubDate>Mon, 20 Apr 2026 20:05:00 GMT</pubDate>
<description>BALTIMORE, April 20, 2026--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended March 31, 2026 on Monday, May 4, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Maloney, Chief Financia</description>
</item>
<item>
<title>Medifast Announces Cooperation Agreement with Steamboat Capital</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-cooperation-agreement-with-steamboat-capital</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-cooperation-agreement-with-steamboat-capital</guid>
<pubDate>Fri, 20 Mar 2026 12:30:00 GMT</pubDate>
<description>BALTIMORE, March 20, 2026--Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Directors has agreed to nominate Parsa Kiai and Jeff Rose from Steamboat Capital Partners LLC as independent director candidates to stand for election at the company’s 2026 Annual Meeting of Stockholders, which is provisionally scheduled for May 19, 2026. These nominations are pursuant to a Cooperation</description>
</item>
<item>
<title>Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients</title>
<link>https://6ix.com/company/medifast-inc/news/scientific-evidence-demonstrates-optaviars-metabolic-health-benefits-opening-the-door-to-qualified-hsafsa-clients</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/scientific-evidence-demonstrates-optaviars-metabolic-health-benefits-opening-the-door-to-qualified-hsafsa-clients</guid>
<pubDate>Fri, 20 Feb 2026 13:30:00 GMT</pubDate>
<description>BALTIMORE, February 20, 2026--As part of its continued focus on improving metabolic health, Medifast® (NYSE: MED) today announced that OPTAVIA’s comprehensive metabolic health system is available for reimbursement on select insurance plans using Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). OPTAVIA clients may be able to save up to 40% on program costs by working with their medical provider and insurance administrator to use pre-tax medical funds, offering accessibility for</description>
</item>
<item>
<title>Medifast Announces Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-fourth-quarter-full-210500603</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-fourth-quarter-full-210500603</guid>
<pubDate>Tue, 17 Feb 2026 21:05:00 GMT</pubDate>
<description>BALTIMORE, February 17, 2026--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full year ended December 31, 2025.</description>
</item>
<item>
<title>Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-fourth-210500911</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-fourth-210500911</guid>
<pubDate>Tue, 03 Feb 2026 21:05:00 GMT</pubDate>
<description>BALTIMORE, February 03, 2026--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full year ended December 31, 2025 on Tuesday, February 17, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Malone</description>
</item>
<item>
<title>People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®</title>
<link>https://6ix.com/company/medifast-inc/news/people-magazine-spotlights-tiffany-howard-133000064</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/people-magazine-spotlights-tiffany-howard-133000064</guid>
<pubDate>Fri, 16 Jan 2026 13:30:00 GMT</pubDate>
<description>BALTIMORE, January 16, 2026--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation of Tiffany Howard, recently featured in People magazine. Tiffany’s journey highlights how OPTAVIA’s comprehensive program, which combines science-backed nutrition, personalized coaching and sustainable habit-building, reversed her metabolic dysfunction1. For Tiffany, this meant several meaningful he</description>
</item>
<item>
<title>OPTAVIA® Premieres Second Docuseries Episode "Health by Design: Spain" Exploring Metabolic Health and Longevity</title>
<link>https://6ix.com/company/medifast-inc/news/optavia-premieres-second-docuseries-episode-133000203</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/optavia-premieres-second-docuseries-episode-133000203</guid>
<pubDate>Thu, 15 Jan 2026 13:30:00 GMT</pubDate>
<description>BALTIMORE, January 15, 2026--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, premiered its newest docuseries episode, "Health by Design: Spain", which explores the cultural, environmental, and community-driven factors promoting long, healthy lives. The second installment in the "Health by Design" series transports viewers to Galicia and Madrid, Spain – spotlighting Galicia, a region renowned for its potential to become t</description>
</item>
<item>
<title>Medifast Announces Planned Leadership Transition</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-planned-leadership-transition-140000633</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-planned-leadership-transition-140000633</guid>
<pubDate>Mon, 05 Jan 2026 14:00:00 GMT</pubDate>
<description>BALTIMORE, January 05, 2026--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabolic health.</description>
</item>
<item>
<title>OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing</title>
<link>https://6ix.com/company/medifast-inc/news/optavia-survey-reveals-80-americans-133000694</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/optavia-survey-reveals-80-americans-133000694</guid>
<pubDate>Tue, 09 Dec 2025 13:30:00 GMT</pubDate>
<description>BALTIMORE, December 09, 2025--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report "Metabolic Health in America: Awareness, Attitudes and Action." The report includes findings based on an online survey conducted by OPTAVIA with KRC Research among a nationally representative group of U.S. adults ages 18–75, recruited to match U.S. Census demographics*. The data highlights a pressing concern: 80% of American adults lack understanding of metabolic health, yet many are</description>
</item>
<item>
<title>Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-scientific-clinical-affairs-team-213000468</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-scientific-clinical-affairs-team-213000468</guid>
<pubDate>Thu, 13 Nov 2025 21:30:00 GMT</pubDate>
<description>BALTIMORE, November 13, 2025--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by unveiling new research findings during ObesityWeek. Hosted by The Obesity Society in Atlanta, Georgia November 4–7, 2025, the annual conference for obesity researchers and clinicians centers on the latest developments in evidence-based obesity science: cutting-edge basi</description>
</item>
<item>
<title>Medifast Announces Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-third-quarter-2025-210500648</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-third-quarter-2025-210500648</guid>
<pubDate>Mon, 03 Nov 2025 21:05:00 GMT</pubDate>
<description>BALTIMORE, November 03, 2025--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025.</description>
</item>
<item>
<title>Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-strategic-shift-metabolic-123000553</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-strategic-shift-metabolic-123000553</guid>
<pubDate>Mon, 27 Oct 2025 12:30:00 GMT</pubDate>
<description>BALTIMORE, October 27, 2025--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a new focus on holistic metabolic health. The company introduced Metabolic Synchronization™ — a breakthrough science that reverses metabolic dysfunction with a targeted reset of the body’s metabolism. Research shows the company’s comprehensive system activates strong and targeted fat burn to improve m</description>
</item>
<item>
<title>Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-third-140000115</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-third-140000115</guid>
<pubDate>Tue, 21 Oct 2025 14:00:00 GMT</pubDate>
<description>BALTIMORE, October 21, 2025--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended September 30, 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.</description>
</item>
<item>
<title>Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes</title>
<link>https://6ix.com/company/medifast-inc/news/evidence-links-5-1-plan-123000806</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/evidence-links-5-1-plan-123000806</guid>
<pubDate>Mon, 15 Sep 2025 12:30:00 GMT</pubDate>
<description>BALTIMORE, September 15, 2025--With more than 90% of U.S. adults classified as metabolically unhealthy1, the silent crisis of metabolic dysfunction continues to escalate. This condition can be linked to a range of challenges, including being overweight and having difficulty maintaining energy, vitality and long-term health and wellbeing. To address this issue, Medifast, the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, is reinforcing its co</description>
</item>
<item>
<title>Medifast Announces Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-second-quarter-2025-200500408</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-second-quarter-2025-200500408</guid>
<pubDate>Mon, 04 Aug 2025 20:05:00 GMT</pubDate>
<description>BALTIMORE, August 04, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025.</description>
</item>
<item>
<title>Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-second-200500486</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-second-200500486</guid>
<pubDate>Mon, 21 Jul 2025 20:05:00 GMT</pubDate>
<description>BALTIMORE, July 21, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended June 30, 2025 on Monday, August 4, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.</description>
</item>
<item>
<title>Medifast Announces First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-first-quarter-2025-200500707</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-first-quarter-2025-200500707</guid>
<pubDate>Mon, 28 Apr 2025 20:05:00 GMT</pubDate>
<description>BALTIMORE, April 28, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025.</description>
</item>
<item>
<title>Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-first-200500404</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announce-financial-results-first-200500404</guid>
<pubDate>Mon, 14 Apr 2025 20:05:00 GMT</pubDate>
<description>BALTIMORE, April 14, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended March 31, 2025 on Monday, April 28, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.</description>
</item>
<item>
<title>Medifast Announces Fourth Quarter and Full Year 2024 Financial Results</title>
<link>https://6ix.com/company/medifast-inc/news/medifast-announces-fourth-quarter-full-210500719</link>
<guid isPermaLink="true">https://6ix.com/company/medifast-inc/news/medifast-announces-fourth-quarter-full-210500719</guid>
<pubDate>Tue, 18 Feb 2025 21:05:00 GMT</pubDate>
<description>BALTIMORE, February 18, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024.</description>
</item>
</channel>
</rss>